With Medicaid at risk, state officials could help put the brakes on DOGE and the chaos generated in Washington, but only with some decisive pushback.
CMS
Posted inHealth and Social Policy
Trump’s Big Choice on Drug Prices
By following through on Biden’s Medicare price negotiation program, he can take credit for prescription reductions. But Big Pharma doesn’t want that to happen.
Posted inHealth and Social Policy
The VA’s Self-Made Dialysis Disaster
The agency has been getting played for years, but is reluctant to change.
Posted inHealth and Social Policy
Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.
Posted inHealth and Social Policy
Manhattan Medicare Murder Mystery
Only about 50 million customers of America’s reigning medical monopoly might have a motive to exact revenge upon the UnitedHealthcare CEO.
Posted inHealth and Social Policy
Dr. Oz and the Stealth Destruction of Medicare
The TV doctor’s scams and fake cures are the least of what makes him so dangerous as Trump’s appointee to head Medicare and Medicaid.
Posted inHealth and Social Policy
The Empty Hope for RFK Jr.
Taking on Big Pharma and Big Ag isn’t a one-man job.
Posted inPolitics
Harris In-Home Care Plan Recognizes Information Gap on Seniors
Trump has been blanketing Pennsylvania with dubious claims that Harris would cut Social Security and Medicare.
Posted inHealth and Social Policy
Medicare Advantage’s $64 Billion Supplemental Benefits Slush Fund
Medicare spends huge sums financing the dental, vision, and other benefits offered by Medicare Advantage plans. A new government report sounds the alert about their potential misuse.
Posted inWorking in America
A Great Week for American Workers
Thanks to autoworkers, baristas, and some Biden administration agencies